Open Therapeutics
PrivateLast Round
Grant
Nov 8, 2022
Company Overview
Open Therapeutics operates in Healthcare & Life Sciences and is based in Minneapolis, Minnesota. Its latest recorded funding round was a Grant round in November 2022.
Open Therapeutics is a biotechnology company that curates and develops open-source medical, biopharma, and synthetic biology-based technologies for the global scientific community.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Blockchain Infrastructure, Tokenization
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Open Therapeutics Comparables
Compare Open Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ResearchHub | 83% | |
| Open Source Pharma Foundation | 82% | |
| Etica Protocol | 77% |
For institutional investors. Book with your work email.
Open Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 8, 2022 | ||||
| Early Funding | Feb 19, 2019 |
For institutional investors. Book with your work email.
Open Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Timmaron Group | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2022
Received grant funding.
- Feb 19, 2019
Raised capital with participation from Timmaron Group.
For institutional investors. Book with your work email.
Open Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Open Therapeutics's valuation, stock price, and market status.
Is Open Therapeutics a public or private company?
Open Therapeutics is a private company.
What is the current stock price of Open Therapeutics?
Open Therapeutics is a private company, so its shares have no public market price. Caplight tracks Open Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Open Therapeutics worth (valuation)?
Valuation information for Open Therapeutics is not publicly available.
Can I buy Open Therapeutics stock?
Open Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Open Therapeutics's last funding round?
Open Therapeutics's most recent funding round was Grant on November 8, 2022.
Who are the main investors in Open Therapeutics?
Key investors in Open Therapeutics include Timmaron Group.
Will Open Therapeutics IPO soon?
No public IPO plans have been announced for Open Therapeutics.
How can I track Open Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Open Therapeutics's shares on secondary markets.